Drug Shortage Report for VIRAZOLE

Last updated on 2023-11-01 History
Report ID 193926
Drug Identification Number 02170140
Brand name VIRAZOLE
Common or Proper name VIRAZOLE
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) RIBAVIRIN
Strength(s) 6G
Dosage form(s) POWDER FOR SOLUTION AEROSOL
Route of administration INHALATION INHALATION
Packaging size n/a
ATC code J05AP
ATC description
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-06-20
Actual start date 2023-06-20
Estimated end date 2023-10-31
Actual end date 2023-10-30
Shortage status Resolved
Updated date 2023-11-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2023-11-01 French Compare
v15 2023-11-01 English Compare
v14 2023-10-26 French Compare
v13 2023-10-26 English Compare
v12 2023-10-19 French Compare
v11 2023-10-19 English Compare
v10 2023-09-15 French Compare
v9 2023-09-15 English Compare
v8 2023-06-22 French Compare
v7 2023-06-22 English Compare
v6 2023-06-21 English Compare
v5 2023-06-15 French Compare
v4 2023-06-15 English Compare
v3 2023-06-13 English Compare
v2 2023-06-08 French Compare
v1 2023-06-08 English Compare

Showing 1 to 16 of 16